Insulin requirements, basal-bolus distribution and basal patterns used by type 1 diabetic patients (T1DM) starting insulin pump therapy (CSII) and after glucose control optimisation

被引：0
|
作者：
Saigi, I. [1 ]
Tundidor, D. [1 ]
Jordana, L. [1 ]
Maria, M. A. [1 ]
Corcoy, R. [1 ]
Chico, A. [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Eduab HSP, Barcelona, Spain
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1006
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effects of severe-moderate physical training in T1DM adolescents treated with either insulin pump (CSII) or basal-bolus (BB) regimen
    Delvecchio, Maurizio
    Pustorino, Elena
    Zecchino, Clara
    Salzano, Giuseppina
    Acquafredda, Angelo
    Cavallo, Luciano
    De Luca, Filippo
    Lombardo, Fortunato
    HORMONE RESEARCH, 2006, 65 : 58 - 58
  • [2] Calculation of the Best Basal-Bolus Combination for Postprandial Glucose Control in Insulin Pump Therapy
    Revert, A.
    Calm, R.
    Vehi, J.
    Bondia, J.
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2011, 58 (02) : 274 - 281
  • [3] Efficacy and safety of insulin glulisine (GLU) versus insulin lispro (LIS) as part of a basal-bolus insulin regimen in children and adolescents with Type 1 diabetes (T1DM)
    Philotheou, A.
    Arslanian, S.
    Blatniczky, L.
    Peterkova, V.
    Souhami, E.
    Danne, T.
    DIABETIC MEDICINE, 2008, 25
  • [4] Comparison of Human Hyaluronidase plus Recombinant Human Insulin (RHI) vs. Insulin Lispro in a Basal-Bolus Regimen in Patients with Type 1 Diabetes (T1DM)
    Buse, John B.
    Garg, Satish K.
    Skyler, Jay S.
    Vaughn, Daniel E.
    Muchmore, Douglas B.
    DIABETES, 2011, 60 : A18 - A19
  • [5] Superior prandial glucose control with insulin aspart compared to regular human insulin in basal bolus therapy with NPH in patients with inadequately controlled T1DM or T2 DM
    Gao, Yan
    Pan, Changyu
    Zou, Dajin
    Xu, Zhangrong
    Liu, Xiaomin
    Guo, Xiaohui
    DIABETES, 2006, 55 : A464 - A464
  • [6] Continuous glucose monitoring improved glycaemic control in patients with type 1 diabetes during 52 weeks of insulin pump therapy as well as with basal-bolus insulin regimen
    Soupal, J.
    Flekac, M.
    Petruzelkova, L.
    Skrha, J., Jr.
    Skrha, J.
    Prazny, M.
    DIABETOLOGIA, 2015, 58 : S476 - S476
  • [7] Efficacy and safety of insulin glulisine (GLU) vs insulin lispro (LIS) as part of a basal-bolus insulin (INS) regimen in children and adolescents with type 1 diabetes (T1DM)
    Philotheou, Areti
    Arslanian, Silva
    Blatniczky, Laszlo
    Peterkova, Valentina
    Souhami, Elisabeth
    Danne, Thomas
    DIABETES, 2008, 57 : A496 - A497
  • [8] Comparison of the soluble basal insulin analog insulin detemir with NPH insulin - A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy
    Hermansen, K
    Madsbad, S
    Perrild, H
    Kristensen, A
    Axelsen, M
    DIABETES CARE, 2001, 24 (02) : 296 - 301
  • [9] Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes
    Chacra, A. R.
    Kipnes, M.
    Ilag, L. L.
    Sarwat, S.
    Giaconia, J.
    Chan, J.
    DIABETIC MEDICINE, 2010, 27 (05) : 563 - 569
  • [10] Switching to Insulin Glargine 300 U/mL (Gla-300) Improves Glycemic Control after Failure of Basal-Bolus Therapy (BBT) with Other Basal Insulins (BI) in Patients (Pts) with Type 1 Diabetes (T1DM)
    Fritsche, Andreas
    Pscherer, Stefan
    Anderten, Helmut
    Pegelow, Katrin
    Seufert, Jochen
    Pfohl, Martin
    DIABETES, 2018, 67
12345